1. Home
  2. DTI vs VRCA Comparison

DTI vs VRCA Comparison

Compare DTI & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Drilling Tools International Corporation

DTI

Drilling Tools International Corporation

HOLD

Current Price

$2.61

Market Cap

88.6M

Sector

Industrials

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.28

Market Cap

88.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTI
VRCA
Founded
1984
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.6M
88.0M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
DTI
VRCA
Price
$2.61
$5.28
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
174.3K
99.9K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$154,446,000.00
$35,577,000.00
Revenue This Year
$2.05
N/A
Revenue Next Year
$4.48
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
1.59
370.22
52 Week Low
$1.65
$3.28
52 Week High
$4.69
$9.82

Technical Indicators

Market Signals
Indicator
DTI
VRCA
Relative Strength Index (RSI) 57.77 50.84
Support Level $2.42 $4.52
Resistance Level $2.70 $5.94
Average True Range (ATR) 0.11 0.41
MACD 0.00 0.06
Stochastic Oscillator 68.55 53.60

Price Performance

Historical Comparison
DTI
VRCA

About DTI Drilling Tools International Corporation

Drilling Tools International Corp is an oilfield services company that designs, engineers, and manufactures rental-focused tools used in onshore and offshore horizontal and directional drilling operations, as well as solutions across the well life cycle. It operates through two geographic segments: Western Hemisphere and Eastern Hemisphere. The Western Hemisphere, which generates the majority of revenue, provides downhole drilling tools and rental services for onshore and offshore operations across North America and Latin America, supported by service centers in the U.S. and Canada. The Eastern Hemisphere covers Europe, the Middle East, and Asia-Pacific, where the company offers drilling and well lifecycle solutions through international service centers across the EMEA and APAC regions.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: